drugset / Trial / NCT00152035

Safety of SPD465 in Treating Adults With ADHD.

NCT00152035 ↗

Phase 3 Completed 505 enrolled Shire
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of SPD465 in the treatment of ADHD. The study will also look at how SPD465 affects sleep.

Timeline

Start
2005-03-10
Primary completion
2006-11-07
Completion
2006-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SPD465 Unknown — —